Omega Therapeutics (OMGA) Competitors

Omega Therapeutics logo
$0.23 +0.01 (+4.22%)
Closing price 02/14/2025 04:00 PM Eastern
Extended Trading
$0.20 -0.03 (-12.97%)
As of 02/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OMGA vs. ENLV, DRRX, CTXR, COCP, CARA, TNXP, SXTP, CDIO, LSB, and LGVN

Should you be buying Omega Therapeutics stock or one of its competitors? The main competitors of Omega Therapeutics include Enlivex Therapeutics (ENLV), DURECT (DRRX), Citius Pharmaceuticals (CTXR), Cocrystal Pharma (COCP), Cara Therapeutics (CARA), Tonix Pharmaceuticals (TNXP), 60 Degrees Pharmaceuticals (SXTP), Cardio Diagnostics (CDIO), Lakeshore Biopharma (LSB), and Longeveron (LGVN). These companies are all part of the "pharmaceutical products" industry.

Omega Therapeutics vs.

Enlivex Therapeutics (NASDAQ:ENLV) and Omega Therapeutics (NASDAQ:OMGA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking.

Enlivex Therapeutics received 28 more outperform votes than Omega Therapeutics when rated by MarketBeat users. Likewise, 80.00% of users gave Enlivex Therapeutics an outperform vote while only 73.68% of users gave Omega Therapeutics an outperform vote.

CompanyUnderperformOutperform
Enlivex TherapeuticsOutperform Votes
56
80.00%
Underperform Votes
14
20.00%
Omega TherapeuticsOutperform Votes
28
73.68%
Underperform Votes
10
26.32%

In the previous week, Omega Therapeutics had 1 more articles in the media than Enlivex Therapeutics. MarketBeat recorded 1 mentions for Omega Therapeutics and 0 mentions for Enlivex Therapeutics. Omega Therapeutics' average media sentiment score of 0.32 beat Enlivex Therapeutics' score of 0.00 indicating that Omega Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Enlivex Therapeutics Neutral
Omega Therapeutics Neutral

1.0% of Enlivex Therapeutics shares are held by institutional investors. Comparatively, 97.5% of Omega Therapeutics shares are held by institutional investors. 12.3% of Enlivex Therapeutics shares are held by insiders. Comparatively, 8.5% of Omega Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Enlivex Therapeutics has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. Comparatively, Omega Therapeutics has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.

Enlivex Therapeutics currently has a consensus price target of $9.50, indicating a potential upside of 804.76%. Omega Therapeutics has a consensus price target of $9.20, indicating a potential upside of 3,903.48%. Given Omega Therapeutics' higher possible upside, analysts plainly believe Omega Therapeutics is more favorable than Enlivex Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enlivex Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Omega Therapeutics
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Enlivex Therapeutics has a net margin of 0.00% compared to Omega Therapeutics' net margin of -902.93%. Enlivex Therapeutics' return on equity of -67.57% beat Omega Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Enlivex TherapeuticsN/A -67.57% -58.45%
Omega Therapeutics -902.93%-213.13%-41.24%

Enlivex Therapeutics has higher earnings, but lower revenue than Omega Therapeutics. Enlivex Therapeutics is trading at a lower price-to-earnings ratio than Omega Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enlivex TherapeuticsN/AN/A-$29.07M-$0.98-1.07
Omega Therapeutics$8.10M1.57-$97.43M-$1.33-0.17

Summary

Enlivex Therapeutics and Omega Therapeutics tied by winning 9 of the 18 factors compared between the two stocks.

Get Omega Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMGA vs. The Competition

MetricOmega TherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$12.72M$3.09B$5.76B$9.21B
Dividend YieldN/A1.67%5.27%3.99%
P/E Ratio-0.1745.4825.5919.43
Price / Sales1.57297.96469.2576.00
Price / CashN/A192.7646.0638.90
Price / Book0.224.057.305.05
Net Income-$97.43M-$40.60M$3.19B$222.81M
7 Day Performance112.78%3.50%1.69%1.29%
1 Month Performance-58.14%4.18%4.12%1.52%
1 Year Performance-94.64%-10.55%22.23%16.53%

Omega Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMGA
Omega Therapeutics
2.8365 of 5 stars
$0.23
+4.2%
$9.20
+3,903.5%
-94.6%$12.72M$8.10M-0.17120Gap Down
High Trading Volume
ENLV
Enlivex Therapeutics
2.709 of 5 stars
$1.09
-0.9%
$9.50
+771.6%
-68.4%$23.34MN/A-1.1170
DRRX
DURECT
3.8452 of 5 stars
$0.75
-1.3%
$5.00
+566.8%
-26.1%$23.28M$8.55M-1.2380Analyst Forecast
Short Interest ↓
News Coverage
CTXR
Citius Pharmaceuticals
3.0926 of 5 stars
$2.70
+1.1%
$54.50
+1,918.5%
-86.5%$23.19MN/A-0.4520Earnings Report
Short Interest ↓
COCP
Cocrystal Pharma
3.582 of 5 stars
$2.28
+24.6%
$7.00
+207.0%
+23.0%$23.19MN/A-1.2310High Trading Volume
CARA
Cara Therapeutics
4.2221 of 5 stars
$5.04
+0.8%
$27.84
+452.4%
-30.8%$23.03M$20.97M-0.2480Positive News
TNXP
Tonix Pharmaceuticals
3.6991 of 5 stars
$11.94
-3.6%
$5,350.00
+44,707.4%
-99.0%$22.33M$7.77M0.0050
SXTP
60 Degrees Pharmaceuticals
1.337 of 5 stars
$0.61
+9.3%
N/A+83.0%$22.13M$250,000.00-0.063
CDIO
Cardio Diagnostics
2.095 of 5 stars
$0.55
-2.2%
$2.00
+266.3%
-62.4%$22.08M$20,000.000.001Negative News
LSB
Lakeshore Biopharma
1.4853 of 5 stars
$2.36
-6.0%
N/AN/A$21.97M$80.82M0.00773Short Interest ↓
Positive News
Gap Down
LGVN
Longeveron
3.4787 of 5 stars
$1.48
-2.6%
$8.67
+485.6%
-68.5%$21.96M$710,000.00-0.2420Short Interest ↓
Positive News

Related Companies and Tools


This page (NASDAQ:OMGA) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners